FOLH1 and prostate carcinoma: Additionally, the uptake of [188Re]Re-DP1-PSMAt and [188Re]Re-DP2-PSMAt (100 kBq) was also assessed in the abovementioned prostate cancer cell lines: both radiotracers exhibited uptake in DU145-PSMA+ cells (13.5 ± 2.7 %AR and 8.3 ±0.7 %AR, respectively) and LNCaP cells (2.8 ± 1.6 %AR and 2.6 ± 1.6 %AR, respectively).